Canton, MA./Las Vegas, October 11, 2019 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that the latest advanced wound care research on Apligraf® and NuShield® will be presented at the Symposium on Advanced Wound Care (SAWC) Fall 2019 meeting, held Oct. 12-14 in Las Vegas. Click here to read more.